Posted on September 19, 2024 What's This About? 🔍 A promising new study examined the combination of two drugs, Rogaratinib Plus Atezolizumab, in patients with locally advanced or metastatic bladder cancer,…
📅 On September 3, 2024, we received a touching request from a family in Poland, whose young daughter Daria, age 5, was diagnosed with a brain stem tumor after a…
📢 Published on June 13, 2024 Researchers from Stanford University have published the results of a study in Nature Medicine that examined the effectiveness of the treatment combining Botensilimab and…
👉Fate can change in an instant. For Roni, 54 years old, a father and husband, that moment came when he reached out to us. Roni was diagnosed with salivary gland…
We want to share with you the touching story of Michal (a pseudonym), a 32-year-old incredible woman battling metastatic breast cancer, who we have been supporting for some time. Our…
📢 ** Published on April 30, 2024** Researchers from McGill University in Montreal conducted a comprehensive study involving 128 clinical trials. In this study, there were two groups of patients:…
Background Adagrasib, also called “Krazati”, is a tablet taken by mouth which inhibits KRAS G12C mutation. It has shown clinical activity in pretreated patients with several tumor types, including colorectal…
Background The use of cannabis for therapeutic benefit has risen exponentially over the past few years with strong public belief in its benefit. This is despite very limited evidence of…
About Locally Advanced Unresectable Metastatic Gastric Cancer and Gastroesophageal Junction Cancer (GEJ) Gastric cancer is the fifth most diagnosed cancer worldwide. Signs and symptoms can include indigestion or heartburn; pain…
